Yao Wei

4PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 08, 2024
TOP CAR with TMIGD2 as a safe and effective costimulatory domain in CAR cells treating human solid tumors.

Christopher D Nishimura, Devin Corrigan, Xiang Yu Zheng

|Dec 07, 2023
Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma.

Phillip M Galbo, Anne Tranberg Madsen, Yang Liu

|Jul 10, 2021
KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target.

Yao Wei, Xiaoxin Ren, Phillip M Galbo

|Apr 14, 2019
FGFR2 Promotes Expression of PD-L1 in Colorectal Cancer via the JAK/STAT3 Signaling Pathway.

Piao Li, Tingting Huang, Qi Zou

Pageof 1

Frequent Collaborators

3 joint publications

Phillip M Galbo

3 joint publications

Xingxing Zang

3 joint publications

Deyou Zheng

2 joint publications

Mou Peng